Synthesis and antiproliferative activity of novobiocin analogues as potential hsp90 inhibitors
- Eur J Med Chem. 2014 Aug 18:83:498-507. doi: 10.1016/j.ejmech.2014.06.067.
- 1. University Paris-Sud, CNRS, BioCIS-UMR 8076, Laboratoire de Chimie Thérapeutique, Equipe Labellisée Ligue Contre Le Cancer, LabEx LERMIT, Faculté de Pharmacie, 5 Rue J.-B. Clément, Châtenay-Malabry F-92296, France.
- 2. Institut Galien-Paris Sud, CNRS, UMR 8612, Faculté de Pharmacie, 5 Rue J.-B. Clément, Châtenay-Malabry F-92296, France.
- 3. University Paris-Sud, CNRS, BioCIS-UMR 8076, Laboratoire de Chimie Thérapeutique, Equipe Labellisée Ligue Contre Le Cancer, LabEx LERMIT, Faculté de Pharmacie, 5 Rue J.-B. Clément, Châtenay-Malabry F-92296, France. Electronic address: [email protected].
- 4. University Paris-Sud, CNRS, BioCIS-UMR 8076, Laboratoire de Chimie Thérapeutique, Equipe Labellisée Ligue Contre Le Cancer, LabEx LERMIT, Faculté de Pharmacie, 5 Rue J.-B. Clément, Châtenay-Malabry F-92296, France. Electronic address: [email protected].
A series of substituted coumarins1-10 was designed and synthesized as a novel class of 4TCNA analogues. Compound 2a showed excellent antiproliferative activity with mean GI50 values at a micromolar level in a diverse set of human Cancer cells (GI50 = 2-30 μM) and induced a high Apoptosis level in MCF-7 breast Cancer cell line. The molecular signature of HSP90 inhibition was assessed by depletion of the Erα HSP90 client protein.